Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$9.2 - $23.86 $1.26 Million - $3.27 Million
-136,952 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$13.47 - $24.89 $46,444 - $85,820
3,448 Added 2.58%
136,952 $2.99 Million
Q3 2020

Nov 16, 2020

BUY
$12.89 - $15.89 $133,037 - $164,000
10,321 Added 8.38%
133,504 $1.92 Million
Q2 2020

Aug 13, 2020

BUY
$8.86 - $15.69 $1.09 Million - $1.93 Million
123,183 New
123,183 $1.78 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.81B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Affinity Wealth Management LLC Portfolio

Follow Affinity Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Wealth Management LLC with notifications on news.